RA Capital Management racap.com

RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics. The firm provides seed funding to startups and leads private, IPO, and follow-on financings for its portfolio companies, thereby driving value creation from idea inception through commercialization.

RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics. The firm provides seed funding to startups...Show all

See All Exits Recent Exits

Phone:

Fax:

200 Berkeley Street
18th Floor
 Boston, 02116
 Massachusetts, United States

RA Capital Management - Investments & Acquisitions

Show Real Data RA Capital Management Investments
See all Recent Investments
Date Company Round Amount Co-investors
2020-05-20Atea PharmaceuticalsSeries D$215MAdage Capital Management, Ally Bridge Group, Bain Capital, Cormorant Asset Management, Morningside Venture Capital, Omega Fund Management, Perceptive Advisors, Redmile Group, Rock Springs Capital, Sectoral Asset Management, and T. Rowe Price
2020-04-01Pandion TherapeuticsSeries B$80MAccess Biotechnology, BioInnovation Capital, Boxer Capital, JDRF T1D Fund, OrbiMed Advisors, Polaris Partners, Roche Venture Fund, SR One, and Versant Ventures
2020-04-01iTeos TherapeuticsSeries B - II$125M6 Dimensions Capital, Boxer Capital, Curative Ventures, Fund+, HBM Partners, Invus Group, Janus Henderson Investors, MPM Capital, RTW Investments, Société Régionale d'Investissement de Wallonie, and Vives
2020-03-31Legend BiotechSeries A$150MHudson Bay Capital Management, Johnson & Johnson Innovation, Lilly Asia Ventures, SMALLCAP World Fund, and Vivo Capital
2020-03-26SutroVaxSeries D$110MAbingworth, CTI Life Sciences Fund, Foresite Capital, Frazier Healthcare Partners, Janus Henderson Investors, Longitude Capital, Medicxi Ventures, Pivotal bioVenture Partners, Roche Venture Fund, and TPG Growth
See all 5 investments